The Global Tyrosine Kinase Inhibitors market reached US$ 51.03 billion in 2023, increased to US$ 53.99 billion in 2024, and is expected to hit US$ 93.97 billion by 2033, growing at a CAGR of 6.4% from 2025 to 2033.
This growth is driven by the rising cancer rates, greater use of precision oncology, and ongoing development in targeted drug creation. The increasing adoption of personalized...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek